Updated overall survival and ctDNA analysis in patients with EGFR T790M-positive advanced non-small cell lung cancer treated with lazertinib in the phase 1/2 LASER201 study
在 1/2 期 LASER201 研究中，对接受 lazertinib 治疗的 EGFR T790M 阳性晚期非小细胞肺癌患者进行了更新的总生存期和 ctDNA 分析。
期刊:BMC Medicine
影响因子:8.3
doi:10.1186/s12916-024-03620-8
Han, Ji-Youn; Ahn, Myung-Ju; Lee, Ki Hyeong; Lee, Yun-Gyoo; Kim, Dong-Wan; Min, Young Joo; Kim, Sang-We; Cho, Eun Kyung; Kim, Joo-Hang; Lee, Gyeong-Won; Lee, Sung Sook; Lee, Na Mi; Jang, Hyun Woo; Han, Heewon; Park, Hyejoo; Lee, Jieon; Cho, Byoung Chul
